Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis

European Respiratory Journal

Volumn 31, Issue 1, 2008, Pages 36-42

  Latzin, P ^a,b,c   Hartl, D ^b   Regamey, N ^a   Frey, U ^a   Schoeni, M H ^a   Casaulta, C ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Allergic bronchopulmonary aspergillosis; Cystic fibrosis; Diagnostic value; Immunoglobulin E; Serum marker; Thymus and activation regulated chemokine

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MARKER; THYMUS AND ACTIVATION REGULATED CHEMOKINE; BIOLOGICAL MARKER; CCL17 PROTEIN, HUMAN; CHEMOKINE;

ARTICLE; ASPERGILLUS FUMIGATUS; BRONCHOPULMONARY ASPERGILLOMA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; ROC CURVE; SCHOOL CHILD; SEROLOGY; ADOLESCENT; BLOOD; CASE CONTROL STUDY; CHEMISTRY; COMPARATIVE STUDY; LUNG ASPERGILLOSIS; METABOLISM;

ADOLESCENT; ALLERGENS; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; ASPERGILLUS FUMIGATUS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHEMOKINE CCL17; CHEMOKINES; CHILD; CYSTIC FIBROSIS; FEMALE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MALE;

EID: 45849115137     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00078107     Document Type: Article

References (32)

1. Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2002; 110: 685-692.
2. Kraemer R, Delosea N, Ballinari P, Gallati S, Crameri R. Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis. Am J Respir Crit Care Med 2006; 174: 1211-1220.
3. Virnig C, Bush RK. Allergic bronchopulmonary aspergillosis: a US perspective. Curr Opin Pulm Med 2007; 13: 67-71.
4. Nelson LA, Callerame ML, Schwartz RH. Aspergillosis and atopy in cystic fibrosis. Am Rev Respir Dis 1979; 120: 863-873.
5. Stevens DA, Moss RB, Kurup VP, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis - state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis 2003; 37: Suppl. 3, S225-S264.
6. Cunningham S, Madge SL, Dinwiddie R. Survey of criteria used to diagnose allergic bronchopulmonary aspergillosis in cystic fibrosis. Arch Dis Child 2001; 84: 89.
7. de Almeida MB, Bussamra MH, Rodrigues JC. Allergic bronchopulmonary aspergillosis in paediatric cystic fibrosis patients. Paediatr Respir Rev 2006; 7: 67-72.
8. Ratjen F, Doring G. Cystic fibrosis. Lancet 2003; 361: 681-689.
9. Burns JL, Emerson J, Stapp JR, et al. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin Infect Dis 1998; 27: 158-163.
10. Skov M, McKay K, Koch C, Cooper PJ. Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis in an area with a high frequency of atopy. Respir Med 2005; 99: 887-893.
11. Mastella G, Rainisio M, Harms HK, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Eur Respir J 2000; 16: 464-471.
12. Hogaboam CM, Carpenter KJ, Schuh JM, Buckland KF. Aspergillus and asthma-any link? Med Mycol 2005; 43: Suppl. 1, S197-S202.
13. Hartl D, Latzin P, Zissel G, Krane M, Krauss-Etschmann S, Griese M. Chemokines indicate allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Am J Respir Crit Care Med 2006; 173: 1370-1376.
14. Casaulta C, Fluckiger S, Crameri R, Blaser K, Schoeni MH. Time course of antibody response to recombinant Aspergillus fumigatus antigens in cystic fibrosis with and without ABPA. Pediatr Allergy Immunol 2005; 16: 217-225.
15. Hemmann S, Nikolaizik WH, Schoni MH, Blaser K, Crameri R. Differential IgE recognition of recombinant Aspergillus fumigatus allergens by cystic fibrosis patients with allergic bronchopulmonary aspergillosis or Aspergillus allergy. Eur J Immunol 1998; 28: 1155-1160.
16. Salvatore F, Scudiero O, Castaldo G. Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes. Am J Med Genet 2002; 111: 88-95.
17. Crameri R. Recombinant Aspergillus fumigatus allergens: from the nucleotide sequences to clinical applications. Int Arch Allergy Immunol 1998; 115: 99-114.
18. Nikolaizik WH, Moser M, Crameri R, et al. Identification of allergic bronchopulmonary aspergillosis in cystic fibrosis patients by recombinant Aspergillus fumigatus I/a-specific serology. Am J Respir Crit Care Med 1995; 152: 634-639.
19. Kurup VP, Banerjee B, Hemmann S, Greenberger PA, Blaser K, Crameri R. Selected recombinant Aspergillus fumigatus allergens bind specifically to IgE in ABPA. Clin Exp Allergy 2000; 30: 988-993.
20. Crameri R, Hemmann S, Ismail C, Menz G, Blaser K. Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis. Int Immunol 1998; 10: 1211-1216.
21. Knutsen AP, Hutcheson PS, Slavin RG, Kurup VP. IgE antibody to Aspergillus fumigatus recombinant allergens in cystic fibrosis patients with allergic bronchopulmonary aspergillosis. Allergy 2004; 59: 198-203.
22. Kurup VP, Knutsen AP, Moss RB, Bansal NK. Specific antibodies to recombinant allergens of Aspergillus fumigatus in cystic fibrosis patients with ABPA. Clin Mol Allergy 2006; 4: 11.
23. Skov M, Pressler T, Jensen HE, Hoiby N, Koch C. Specific IgG subclass antibody pattern to Aspergillus fumigatus in patients with cystic fibrosis with allergic bronchopulmonary aspergillosis (ABPA). Thorax 1999; 54: 44-50.
24. Krane M, Griese M. Surfactant protein D in serum from patients with allergic bronchopulmonary aspergillosis. Eur Respir J 2003; 22: 592-595.
25. Shoseyov D, Brownlee KG, Conway SP, Kerem E. Aspergillus bronchitis in cystic fibrosis. Chest 2006; 130: 222-226.
26. Hartl D, Buckland KF, Hogaboam CM. Chemokines in allergic aspergillosis - from animal models to human lung diseases. Inflamm Allergy Drug Targets 2006; 5: 219-228.
27. Meier A, Kirschning CJ, Nikolaus T, Wagner H, Heesemann J, Ebel F. Toll-like receptor (TLR) 2 and TLR4 are essential for Aspergillus-induced activation of murine macrophages. Cell Microbiol 2003; 5: 561-570.
28. Vulcano M, Albanesi C, Stoppacciaro A, et al. Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo. Eur J Immunol 2001; 31: 812-822.
29. D'Ambrosio D, Iellem A, Bonecchi R, et al. Selective upregulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J Immunol 1998; 161: 5111-5115.
30. Renauld JC. New insights into the role of cytokines in asthma. J Clin Pathol 2001; 54: 577-589.
31. Miyazaki E, Nureki S, Ono E, et al. Circulating thymus-and activation-regulated chemokine/CCL17 is a useful biomarker for discriminating acute eosinophilic pneumonia from other causes of acute lung injury. Chest 2007; 131: 1726-1734.
32. Leung TF, Wong CK, Lam CWK, et al. Plasma TARC concentration may be a useful marker for asthmatic exacerbation in children. Eur Respir J 2003; 21: 616-620.